Bioiberica reveals women only clinical study on collavant n2 native (undernatured) type II collagen

Bioiberica, a global life science company with more than 45 years’ experience in the research, production and commercialisation of molecules of high biological and therapeutic value, proudly presents the latest scientific evidence behind its native (undenatured) type II collagen – Collavant n2. The women-only study explored the effects … Read More

0
ChromaDex Corp study report

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson’s Disease (PD) Building on a growing body of research showcasing NR … Read More

0
1 2 3 4 21